Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8802667 Benzodiazepine derivatives

Patent 8802667 was granted and assigned to Immunogen, Inc. on August, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8802667

Patent Inventor Names

Nathan Elliott Fishkin0

Michael Louis Miller0

Ravi V. J. Chari0

Robert Yongxin Zhao0

Wei Li0

Date of Patent

August 12, 2014

Patent Application Number

13826181

Date Filed

March 14, 2013

Patent Citations Received

‌

US Patent 11912779 Compositions and methods of treating facioscapulohumeral muscular dystrophy

‌

US Patent 11834510 Anti-transferrin receptor antibodies and uses thereof

‌

US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy

‌

US Patent RE49918 Cytotoxic benzodiazepine derivatives

‌

US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy

‌

US Patent 11707532 Compositions and methods of treating muscle dystrophy

‌

US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy

Patent Primary Examiner

‌

Bruck Kifle

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8802667 Benzodiazepine derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API